Sellas Life Sciences Group Inc (NASDAQ:SLS)
| 1.68 Delayed Data As of May 26 |  +0.11 / +7.01%Today’s Change | 1.17 Today|||52-Week Range 5.58 | -28.81% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 0.00 | -- | -- | 100.0K | ||
| Operating Expenses | Gross Income | 0.00 | 0.00 | 0.00 | -100.0K | |
| General Expenses | 6.5M | 3.1M | 6.3M | 4.3M | ||
| Research And Development | 1.6M | 1.7M | 3.7M | 1.9M | ||
| Total Operating Expenses | 6.5M | 3.1M | 6.3M | 4.4M | ||
| Non-Operating Expenses | Operating Income | -6.5M | -3.1M | -6.3M | -4.4M | |
| Extraordinary Credit | 1.2M | 3.0M | -- | 195.0K | ||
| Extraordinary Charge | -452.0K | -162.0K | -8.6M | -387.0K | ||
| Interest Expense On Debt | 122.0K | 74.0K | -- | -- | ||
| Other Expenses | -42.0K | 0.00 | 0.00 | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -5.9M | -290.0K | -14.9M | -4.5M | |
| Income Taxes | -163.0K | 0.00 | -1.5M | 0.00 | ||
| Preferred Dividend | 0.00 | -8.7M | 0.00 | 0.00 | ||
| Net Income | -8.5M | -781.0K | -13.3M | -5.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 6.8M | 17.6M | 22.0M | 22.4M | |
| Shares To Calculate EPS Diluted | 6.8M | 17.6M | 22.0M | 22.4M | ||
| Earnings Per Share | EPS | -$1.26 | -$0.53 | -$0.40 | -$0.22 | |
| EPS Diluted | -$1.26 | -$0.54 | -$0.60 | -$0.22 | ||
